Search Results - "Koukouras, Dimitrios"

The Nordbord usefulness in football: a systematic review of the pros and cons by Koukouras, Dimitrios, Tere, Atharva, Koukouras, Petros, Jemni, Monèm

“…Since 2016 and the introduction of Nordbord to the world, a variety of sports and disciplines have used the device to inform everyday decision-making, such as…”
Get full text

Expression of p27KIP1, p21WAF1 and p53 does Not Correlate with Prognosis in Node-negative Invasive Ductal Carcinoma of the Breast by KOUREA, Helen P, KOUTRAS, Angelos K, KALOFONOS, Haralambos P, ZOLOTA, Vassiliki, GRIMANI, Irene, TZORACOELEFTHERAKIS, Evangelos, KOUKOURAS, Dimitrios, FOUNTZILAS, George, GOGAS, Helen, KYRIAKOU, Kyriakos, ADAMOU, Adamos

“…The expressions of p27 Kip1 (p27) and p21 Waf1 (p21) cyclin-dependent kinase inhibitors and p53 were examined in a series of 170 node-negative breast…”
Get full text

Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial by Markopoulos, Christos, Tzoracoleftherakis, Evagelos, Polychronis, Athanassios, Venizelos, Basileios, Dafni, Urania, Xepapadakis, Grigorios, Papadiamantis, John, Zobolas, Vasilios, Misitzis, John, Kalogerakos, Kyriakos, Sarantopoulou, Angeliki, Siasos, Nikolaos, Koukouras, Dimitrios, Antonopoulou, Zoh, Lazarou, Spyros, Gogas, Helen

“…The aim of this multicenter, phase III, prospective open label clinical trial was to investigate the effect of risedronate (R) on bone mineral density (BMD) in…”
Get full text

Fournier's gangrene, a urologic and surgical emergency: presentation of a multi-institutional experience with 45 cases by Koukouras, Dimitrios, Kallidonis, Panagiotis, Panagopoulos, Constantinos, Al-Aown, Abhulrahman, Athanasopoulos, Anastasios, Rigopoulos, Christos, Fokaefs, Eleftherios, Stolzenburg, Jens-Uwe, Perimenis, Petros, Liatsikos, Evangelos

“…To review multi-institutional, multidisciplinary experience in the management of Fournier's gangrene (FG) in an attempt to identify etiologic parameters as…”
Get more information

Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial by Markopoulos, Christos, Tzoracoleftherakis, Evagelos, Koukouras, Dimitrios, Venizelos, Basileios, Zobolas, Vasilios, Misitzis, John, Xepapadakis, Grigorios, Gogas, Helen

“…Purpose We investigated whether age at anastrozole (A) initiation influences the effect of treatment on bone mineral density (BMD). We conducted a post hoc…”
Get full text

Percutaneous minimally invasive management of iatrogenic ureteral injuries by Koukouras, Dimitrios, Petsas, Theodore, Liatsikos, Evangelos, Kallidonis, Panagiotis, Sdralis, Elias K, Adonakis, Georgios, Panagopoulos, Constantinos, Al-Aown, Abhulrahman, Decavalas, Georgios, Perimenis, Petros, Siablis, Dimitrios, Karnabatidis, Dimitrios

“…To present experience with the percutaneous management of iatrogenic ureteral injuries. Eighteen women and six men with a mean age of 59.3 years (range 33-80…”
Get more information

Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy by Markopoulos, Christos, Dafni, Urania, Misitzis, John, Zobolas, Vasilios, Tzoracoleftherakis, Evagelos, Koukouras, Dimitrios, Xepapadakis, Grigorios, Papadiamantis, John, Venizelos, Basileios, Antonopoulou, Zoh, Gogas, Helen

“…Extended adjuvant endocrine therapy for breast cancer with aromatase inhibitors may potentially alter the lipid profile of postmenopausal patients and thus…”
Get full text

Association of estrogen receptor alpha (ERα) gene polymorphisms with endometrial thickness and lipid profile in women with breast cancer treated with aromatase inhibitors by Koukouras, Dimitrios, Marioli, Dimitra J., Papadopoulos, Kostas, Adonakis, George L., Armeni, Anastasia K., Georgopoulos, Neoklis A., Decavalas, George

“…Aromatase inhibitors (AIs) provide an alternative to tamoxifen as an adjuvant therapy for post-menopausal, hormone-receptor positive breast cancer patients…”
Get full text

Increased frequency of thyroid nodules and breast fibroadenomas in women with uterine fibroids by Spinos, Nikitas, Terzis, George, Crysanthopoulou, Athina, Adonakis, George, Markou, Kostas B, Vervita, Vasiliki, Koukouras, Dimitrios, Tsapanos, Vasilios, Decavalas, George, Kourounis, George, Georgopoulos, Neoklis A

“…Fibroids or leiomyomas or myomas of the uterus are the most common benign gynecologic disease, while fibroadenomas of the breast are most frequently seen in…”
Get more information

A web-based system for supporting collaboration towards resolving oncology issues by Karacapilidis, Nikos, Koukouras, Dimitrios

“…The coordinated consideration of diverse perspectives and knowledge sources in medical decision-making contexts is undoubtedly of crucial importance, in that…”
Get full text

Non-palpable breast carcinomas: Correlation of mammographically detected malignant-appearing microcalcifications and epidermal growth factor receptor (EGFR) family expression by Badra, Filitsa A., Karamouzis, Michalis V., Ravazoula, Panagiota, Likaki-Karatza, Eleni, Tzorakoleftherakis, Evagelos, Koukouras, Dimitrios, Iconomou, Gregorios, Xiros, Nikolaos, Siablis, Dimitrios, Papavassiliou, Athanasios G., Kalofonos, Haralabos P.

“…Malignant-appearing microcalcifications (MAMCs) represent one of the earliest mammographic findings of non-palpable breast carcinomas (NPBCs). In the present…”
Get full text

Non‐palpable breast carcinomas: Correlation of mammographically detected malignant‐appearing microcalcifications and molecular prognostic factors by Karamouzis, Michalis V., Likaki‐Karatza, Eleni, Ravazoula, Panagiota, Badra, Filitsa A., Koukouras, Dimitrios, Tzorakoleftherakis, Evagelos, Papavassiliou, Athanasios G., Kalofonos, Haralambos P.

“…Screening mammography has greatly increased the number of non‐palpable breast carcinomas diagnosed in asymptomatic women. Malignant‐appearing…”
Get full text

Hepatic artery aneurysm complicating intra-arterial chemotherapy for hepatocellular carcinoma by Evangelos, Tzoracoleftherakis, Vassiliki, Patrinou, Dimitrios, Koukouras, Theodoros, Petsas

“…We present a rare case of asymptomatic hepatic artery aneurysm that developed during therapy in a 65-year-old man who received hepatic intra-arterial…”
Get more information

Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer by Georgopoulos, Neoklis A., Adonakis, George L., Fotopoulos, Andreas, Koika, Vasiliki, Spinos, Nikitas, Saltamavros, Alexandros, Keramopoulos, Antonios, Koukouras, Dimitrios, Decavalas, George, Kourounis, George S.

“…In postmenopausal women with estrogen receptor (ER)-positive breast cancer, long-term tamoxifen administration has proved beneficial after surgical treatment…”
Get full text

Prognostic significance of factors affecting disease free interval and overall survival for Stage II breast cancer in Greece by Vorgias, George, Koukouras, Dimitrios, Paleogianni, Victoria, Tzoracoeleftherakis, Evangelos

Get full text

Acute lymphoblastic leukemia relapse in the breast diagnosed with gray‐scale and color Doppler sonography by Likaki‐Karatza, Eleni, Mpadra, Filitsa A., Karamouzis, Michalis V., Ravazoula, Panagiota, Koukouras, Dimitrios, Margariti, Sofia, Dimopoulos, Ioannis

“…Extramedullary relapses of acute lymphoblastic leukemia (ALL) in children and young adults are rare and in most cases are localized in the central nervous…”
Get full text

Prognostic significance of factors affecting disease free interval and overall survival for Stage II breast cancer in Greece: A multivariate cohort study by Vorgias, George, Koukouras, Dimitrios, Paleogianni, Victoria, Tzoracoeleftherakis, Evangelos

“…Background: Univariate analysis evaluates the impact of a prognostic factor on survival rates, either disease free (DFI) or overall (OS). Since many of the…”
Get full text

Adjuvant tamoxifen versus tamoxifen plus CMF in the treatment of early breast cancer in Greece. Fifteen-year results of a randomised prospective trial and the potential risks of the antioestrogen by Vorgias, G, Koukouras, D, Tzoracoeleftherakis, E, Paleogianni, V, Androulakis, J

“…CMF and Tamoxifen are the most commonly administered drugs for the adjuvant treatment of early-stage breast cancer. We present the 15-year follow-up of our…”
Get more information

Prognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group study by Fountzilas, G, Vasilaros, S, Koukouras, D, Malamos, N, Pectasides, D, Adamou, A, Nenopoulou, E, Kiriakou, K, Zouvani, I, Katsohis, K, Kappas, A, Skopa, C, Semoglou, C, Fahantidis, E, Konstantaras, C, Vasilaki, E, Economopoulos, T, Bacoyiannis, H, Bafaloukos, D, Razi, E, Polichronis, A, Androulakis, G, Papaioannou, T, Pavlidis, N, Kosmidis, P

“…The independent effects of several patient, tumor and treatment-related prognostic factors on relapse-free survival (RFS) and overall survival (OS) were…”
Get more information

Acute lymphoblastic leukemia relapse in the breast diagnosed with gray-scale and color Doppler sonography by Likaki-Karatza, Eleni, Mpadra, Filitsa A., Karamouzis, Michalis V., Ravazoula, Panagiota, Koukouras, Dimitrios, Margariti, Sofia, Dimopoulos, Ioannis

Get full text